888 related articles for article (PubMed ID: 18787734)
21. Clinical outcome and prognostic factors of patients with pyogenic liver abscess requiring intensive care.
Chen W; Chen CH; Chiu KL; Lai HC; Liao KF; Ho YJ; Hsu WH
Crit Care Med; 2008 Apr; 36(4):1184-8. PubMed ID: 18379245
[TBL] [Abstract][Full Text] [Related]
22. Predictors of mortality in patients with pyogenic liver abscess.
Chen SC; Tsai SJ; Chen CH; Huang CC; Lin DB; Wang PH; Chen CC; Lee MC
Neth J Med; 2008 May; 66(5):196-203. PubMed ID: 18490797
[TBL] [Abstract][Full Text] [Related]
23. Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome.
Anatoliotaki M; Valatas V; Mantadakis E; Apostolakou H; Mavroudis D; Georgoulias V; Rolston KV; Kontoyiannis DP; Galanakis E; Samonis G
Infection; 2004 Apr; 32(2):65-71. PubMed ID: 15057569
[TBL] [Abstract][Full Text] [Related]
24. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
25. Brain abscess in 142 patients: factors influencing outcome and mortality.
Tseng JH; Tseng MY
Surg Neurol; 2006 Jun; 65(6):557-62; discussion 562. PubMed ID: 16720170
[TBL] [Abstract][Full Text] [Related]
26. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of bloodstream infections in burn patients: An 11-year retrospective study.
Patel BM; Paratz JD; Mallet A; Lipman J; Rudd M; Muller MJ; Paterson DL; Roberts JA
Burns; 2012 Aug; 38(5):685-90. PubMed ID: 22348799
[TBL] [Abstract][Full Text] [Related]
28. Recurrent and relapsing peritonitis: causative organisms and response to treatment.
Szeto CC; Kwan BC; Chow KM; Law MC; Pang WF; Chung KY; Leung CB; Li PK
Am J Kidney Dis; 2009 Oct; 54(4):702-10. PubMed ID: 19577352
[TBL] [Abstract][Full Text] [Related]
29. Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis.
Albertson TE; Panacek EA; MacArthur RD; Johnson SB; Benjamin E; Matuschak GM; Zaloga G; Maki D; Silverstein J; Tobias JK; Haenftling K; Black G; Cowens JW;
Crit Care Med; 2003 Feb; 31(2):419-27. PubMed ID: 12576946
[TBL] [Abstract][Full Text] [Related]
30. Update on bacterial conjunctivitis in South Florida.
Cavuoto K; Zutshi D; Karp CL; Miller D; Feuer W
Ophthalmology; 2008 Jan; 115(1):51-6. PubMed ID: 17572497
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors and antibiotics in Vibrio vulnificus septicemia.
Liu JW; Lee IK; Tang HJ; Ko WC; Lee HC; Liu YC; Hsueh PR; Chuang YC
Arch Intern Med; 2006 Oct; 166(19):2117-23. PubMed ID: 17060542
[TBL] [Abstract][Full Text] [Related]
32. Risk factors and causative organisms in microbial keratitis.
Green M; Apel A; Stapleton F
Cornea; 2008 Jan; 27(1):22-7. PubMed ID: 18245962
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.
Del Pozo JL; Alonso M; Serrera A; Hernaez S; Aguinaga A; Leiva J
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):208-12. PubMed ID: 19026506
[TBL] [Abstract][Full Text] [Related]
35. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C
Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
37. [Bacteremia in children with tumors or malignant diseases 1991-2000].
Alfredsdóttir IH; Thors VS; Gudnason T; Jónmundsson G; Kristinsson JR; Jónsson OG; Kristinsson KG; Haraldsson A
Laeknabladid; 2008 Jul; 94(7-8):531-9. PubMed ID: 18591728
[TBL] [Abstract][Full Text] [Related]
38. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for treatment failure in patients with ventilator-associated pneumonia receiving appropriate antibiotic therapy.
Gursel G; Aydogdu M; Ozyilmaz E; Ozis TN
J Crit Care; 2008 Mar; 23(1):34-40. PubMed ID: 18359419
[TBL] [Abstract][Full Text] [Related]
40. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
Oliveira MS; Prado GV; Costa SF; Grinbaum RS; Levin AS
J Antimicrob Chemother; 2008 Jun; 61(6):1369-75. PubMed ID: 18367459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
